Volta, Nova Scotia Health Authority, QEII Foundation, BioNova and the Atlantic Canada Opportunities Agency are pleased to announce Adaptiiv Medical Technologies Inc. as the winner of the first Health Challenge Pitch Event focusing on Cancer Care. 

On June 19, Adaptiiv Medical Technologies Inc. – whose turn-key solution enables the design of patient-specific, radiation treatment accessories created via 3D printing that effectively improve treatment accuracy and patient experience – had 10 minutes to present their medical technology to a panel of judges virtually. Judges were then given five minutes to ask questions of the presenters. The company will receive $100,000 and the Nova Scotia Health Authority will now consider adopting their technology for use in regional hospitals. 

This event was the first of five virtual pitch competitions focusing on health innovation; it was created to drive innovation in the medtech space and encourage the adoption of technologies that exist to improve the accuracy and level of care medical practitioners require to make concise, life-saving diagnoses and treatments for patients in Atlantic Canada.

The next pitch event topic will focus on another health priority identified by the Nova Scotia Health Authority, and will be announced in the coming weeks; applications will open shortly afterward. 

Visit voltaeffect.com/health-challenge to learn more about the event and find updates on the next topic. 

Quotes:

“Volta is incredibly proud to support the work NSHA is doing to bring innovative technologies into regional hospitals to enhance patient care. Their focus on driving innovation, while also providing a spotlight to medtech companies in the region, is truly inspiring. We are very excited to grow this partnership and look forward to announcing the next Health Challenge priority in the coming weeks.”  

– Martha Casey, Volta Interim CEO, and COO

“Through the Health Challenge, we have created a supportive and collaborative space for competition that will generate some truly powerful and creative health solutions for Nova Scotians. The impact on the lives of Nova Scotians living with cancer is central to today’s challenge and I am confident that these innovative solutions will make a difference.”

– Dr. Gail Tomblin Murphy, Vice President, Research, Innovation & Discovery and CNE, Nova Scotia Health Authority 

“BioNova has been advocating on behalf of our industry for the adoption of health innovation within our local health care system for many years and we’re going to continue to push this initiative forward through BioFuture 2030, our growth plan for the sector.”

– Scott Moffitt, Executive Director, BioNova

“The QEII Foundation has a long-standing history of supporting cancer care priorities at the QEII – funding lifesaving clinics, equipment, treatment advancements and research. It is exciting to be part of finding innovative solutions to cancer care treatments for patients who need it most.”

– Bill Bean, President and CEO, QEII Foundation 

Related articles categorized under Blog